American Journal of Cardiology
Volume 102, Issue 5, Supplement , Pages 38G-41G, 8 September 2008

Percutaneous Coronary Intervention for Myocardial Infarction with Left Ventricular Dysfunction

  • James D. Flaherty, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
    • Corresponding Author InformationAddress for reprints: James D. Flaherty, MD, Assistant Professor of Medicine, Division of Cardiology, 251 East Huron Street, Galter 8-130, Chicago, Illinois 60611
  • ,
  • Charles J. Davidson, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
  • ,
  • David P. Faxon, MD

      Affiliations

    • Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

Patients who have had a myocardial infarction (MI) are at high risk for developing left ventricular dysfunction (LVD), which predisposes them to heart failure and is associated with an increased mortality risk. Early coronary revascularization, either with percutaneous coronary intervention or coronary artery bypass graft surgery, plays an important role in the preservation and restoration of left ventricular function after MI. This article discusses the effects of primary and nonemergent percutaneous coronary revascularization procedures on survival, left ventricular function, and the occurrence of complications, such as recurrent MI and stroke, compared with the effects of thrombolytic therapy. In addition, this article describes rescue revascularization procedures for patients who failed thrombolysis and those presenting relatively late or with negative electrocardiographic findings. Advanced interventional techniques, such as percutaneous ventricular assist devices and bioabsorbable stents, are very promising and may potentially help improve the outcomes of post-MI patients with LVD; however, the use of these techniques requires further validation.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

PII: S0002-9149(08)00999-5

doi:10.1016/j.amjcard.2008.06.009

American Journal of Cardiology
Volume 102, Issue 5, Supplement , Pages 38G-41G, 8 September 2008